Skip to Content

WATSON 453 (Guanfacine 2 mg)

Pill with imprint WATSON 453 is Orange, Round and has been identified as Guanfacine hydrochloride 2 mg. It is supplied by Watson Pharmaceuticals.

Guanfacine is used in the treatment of adhd; high blood pressure; tourette's syndrome and belongs to the drug class antiadrenergic agents, centrally acting. There is no proven risk in humans during pregnancy. Guanfacine 2 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 453

Guanfacine hydrochloride 2 mg WATSON 453
Guanfacine hydrochloride 2 mg WATSON 453  Front
Guanfacine hydrochloride 2 mg WATSON 453  Back
Guanfacine hydrochloride 2 mg WATSON 453

Guanfacine hydrochloride

2 mg
8.00 mm
Prescription only
Drug Class:
Antiadrenergic agents, centrally acting
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals
Inactive Ingredients:
lactose anhydrous
D&C Yellow No. 10
FD&C Red No. 40
povidone k29/32
stearic acid
microcrystalline cellulose
aluminum oxide
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.